Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Kinross Gold Corporation
Kinross announces public equity offering - 20.9 million shares at US$17.25 per share - Gross proceeds approximately US$360.5 million
February 8th, 2009
Kinross Gold Corporation (TSX: K; NYSE: KGC) ("Kinross" or the "Company") announced that it has entered into an agreement with a syndicate of underwriters led by UBS Securities Canada Inc. for a bought deal public offering of 20.9 million common shares of Kinross at a price of US$17.25 per common share. The Company has also granted to the underwriters an over-allotment option, exercisable for a period of 30 days from the date of closing of the offering, to purchase up to an additional 3,135,000 common shares at the offering price. The gross proceeds of the offering will be approximately US$360.5 million (US$414.6 million if the over-allotment option is exercised in...
Source: Pharma Investments, Ventures & Law Weekly (2009-02-08)
|
